Cefepime (250mg)+ Tazobactum (31.25mg)
Magnova 250 mg/31.25 mg Injection should only be administered under the supervision of a healthcare professional. Do not miss any scheduled appointments for taking this medicine. The course of the medicine should be completed even if you feel better.The common side effects of this medicine are nausea, vomiting, diarrhea, rashes, etc. You may also experience injection site redness, swelling, and pain that goes away with time. If any of the side effects get aggravated, you must consult your doctor immediately. If you experience any allergic reaction (rashes, itching, swelling, shortness of breath, etc.), you must seek immediate medical help.Before taking this medicine, you should tell your doctor if you are taking any medicines for any health condition. Pregnant or breastfeeding women should also consult with their doctor before taking it. Avoid drinking alcohol as it can cause excessive drowsiness with this medicine. It usually does not impair your ability to drive, but you should not drive if it makes you feel sleepy or dizzy.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Magnova
1 Injection
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Magnova 250 mg/31.25 mg Injection is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria.
Related Warnings
Caution is advised when consuming alcohol with Magnova 250 mg/31.25 mg Injection. Please consult your doctor.
Magnova 250 mg/31.25 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Magnova 250 mg/31.25 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Magnova 250 mg/31.25 mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Magnova 250 mg/31.25 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Magnova 250 mg/31.25 mg Injection may be needed. Please consult your doctor.
Magnova 250 mg/31.25 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Magnova 250 mg/31.25 mg Injection may not be needed in these patients. Please consult your doctor.
Usually, Magnova 250 mg/31.25 mg Injection starts working soon after taking it. However, it may take some days to kill all the harmful bacteria and make you feel better.
Inform your doctor if you don't feel better after finishing the full course of treatment. Also, inform him if your symptoms are getting worse while using this medicine.
No, do not stop taking Magnova 250 mg/31.25 mg Injection and complete the full course of treatment even if you feel better. Your symptoms may improve before the infection is completely cured.
